Science Explorer Interactive view Map
Company · Cambridge · United States

Tango Therapeutics (United States)

Research works
73
▲ 334% vs 2013–17
Citations
1.5k
19.9 per fractional work
Top-10% rate
17.8%
record average 16.5%
Open access
52%
world 28%

Not ranked overall: Tango Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

What does Tango Therapeutics (United States) specialise in?

Where its research is concentrated relative to its size: Molecular Biology takes 18.6× the share of its output that it takes of world research.

  1. Molecular BiologySubfield · 22.4 works19×
  2. Biochemistry, Genetics and Molecular BiologyField · 24.3 works11×
  3. Life SciencesDomain · 28.7 works5.5×
← less than its size predictsmore →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.55× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 11.41× its world share, 24 worksBiochemistry, Geneti…Immunology and Microbiology: 6.10× its world share, 2 worksImmunology and Micro…Neuroscience: 1.44× its world share, 1 worksNeuroscienceChemistry: 1.64× its world share, 1 worksChemistryComputer Science: 0.05× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.27× its world share, 0 worksEarth and Planetary …Engineering: 0.10× its world share, 1 worksEngineeringEnvironmental Science: 0.38× its world share, 1 worksEnvironmental ScienceHealth Professions: 0.11× its world share, 0 worksHealth ProfessionsMedicine: 0.98× its world share, 8 worksMedicinePsychology: 0.09× its world share, 0 worksPsychologySocial Sciences: 0.15× its world share, 1 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 11.4×. Every wedge is a field page.

Who are the top researchers at Tango Therapeutics (United States)?

Ranked on the composite score, Jannik N. Andersen, William D. Mallender and Alan Huang lead among researchers whose main affiliation is Tango Therapeutics (United States).

  1. 1 Jannik N. Andersen United States · #711,560 worldwide 69 citations · 30 works
  2. 2 William D. Mallender United States · #962,448 worldwide 56 citations · 18 works
  3. 3 Alan Huang United States · #1,537,909 worldwide 7 citations · 27 works
All ranked researchers at Tango Therapeutics (United States)

Which keywords describe research at Tango Therapeutics (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Transcriptional Regulation, Cell Proliferation, Epigenetic Regulation, Arginine Methylation, Protein Arginine Methyltransferases, Cancer Therapy and Tumor Microenvironment.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 26 words, with their numbers
  1. Cancer17▲ 32×11 topics
  2. Transcriptional Regulation15▲ 240×4 topics
  3. Cell Proliferation15▲ 433×3 topics
  4. Epigenetic Regulation15▲ 170×2 topics
  5. Arginine Methylation14▲ 1316×1 topic
  6. Protein Arginine Methyltransferases14▲ 1316×1 topic
  7. Cancer Therapy5▲ 22×8 topics
  8. Tumor Microenvironment4▲ 20×6 topics
  9. Cell Death2▲ 21×3 topics
  10. Angiogenesis2▲ 14×2 topics
  11. Cancer Immunotherapy2▲ 30×3 topics
  12. Fibroblast Activation Protein2▲ 105×1 topic
  13. Immunosuppression2▲ 51×1 topic
  14. Homologous Recombination2▲ 93×2 topics
  15. Gene Expression2▲ 6.0×4 topics
  16. Genome Engineering1▲ 52×1 topic
  17. Inflammation1▲ 1.57×9 topics
  18. RNA-Guided1▲ 52×1 topic
  19. BRCA Mutation1▲ 136×1 topic
  20. Nanoparticles1▲ 2.4×3 topics
  21. PARP Inhibitors1▲ 136×1 topic
  22. Glycosylation1▲ 24×2 topics
  23. Medicinal Chemistry1▲ 10.0×3 topics
  24. Proteasome1▲ 76×1 topic
  25. Ubiquitin1▲ 76×1 topic
  26. Immunotherapy1▲ 3.6×4 topics

Which research topics does Tango Therapeutics (United States) publish most on?

By volume in 2022–2025: Cancer-related gene regulation, Peptidase Inhibition and Analysis, CRISPR and Genetic Engineering and PARP inhibition in cancer therapy.

  1. 1 Cancer-related gene regulation Molecular Biology 14 works
  2. 2 Peptidase Inhibition and Analysis Oncology 2 works
  3. 3 CRISPR and Genetic Engineering Molecular Biology 1 works
  4. 4 PARP inhibition in cancer therapy Oncology 1 works
  5. 5 Ubiquitin and proteasome pathways Molecular Biology 1 works
  6. 6 CAR-T cell therapy research Oncology 1 works
  7. 7 Phagocytosis and Immune Regulation Immunology 1 works
  8. 8 Synthesis and Catalytic Reactions Organic Chemistry 1 works
  9. 9 Nuclear Receptors and Signaling Cellular and Molecular Neuroscience 1 works
  10. 10 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available52.4%not open47.6%

World: 28% of research is openly available.

with international co-authors13.4%domestic only86.6%

World: 19% is written across borders.

How has Tango Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 334% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.